Xilio Therapeutics, Inc. (XLO)
7.60
-0.10
(-1.30%)
USD |
NASDAQ |
Jun 08, 16:00
7.60
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics Shareholders Equity (Quarterly) : 72.54M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Verastem, Inc. | 81.78M |
| KalVista Pharmaceuticals, Inc. | -19.65M |
| Opus Genetics, Inc. | -45.84M |
| Sensei Biotherapeutics, Inc. | 23.01M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 163.49M |
| Total Liabilities (Quarterly) | 90.94M |
| Debt to Equity Ratio | 0.0915 |
| Current Ratio | 3.590 |
| Net Debt Paydown Yield | 0.62% |